AAAAAA

   
Results: 1-8 |
Results: 8
Edg2 receptor functionality: Gi alpha 1 coexpression and fusion protein studies
Authors: McAllister, G Stanton, JA Salim, K Handford, EJ Beer, MS
Citation: G. Mcallister et al., Edg2 receptor functionality: Gi alpha 1 coexpression and fusion protein studies, MOLEC PHARM, 58(2), 2000, pp. 407-412
4-hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: Selective h5-HT1D agonists for the treatment of migraine.
Authors: Bourrain, S Neduvelil, JG Beer, MS Stanton, JA Showell, GA MacLeod, AM
Citation: S. Bourrain et al., 4-hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: Selective h5-HT1D agonists for the treatment of migraine., BIOORG MED, 9(23), 1999, pp. 3369-3374
2,7-Diazabicyclo[3.3.0]octanes as novel h5-HT1D receptor agonists
Authors: Russell, MGN Beer, MS Stanton, JA Sohal, B Mortishire-Smith, RJ Castro, JL
Citation: Mgn. Russell et al., 2,7-Diazabicyclo[3.3.0]octanes as novel h5-HT1D receptor agonists, BIOORG MED, 9(17), 1999, pp. 2491-2496
Aesculapius: A modern tale
Authors: Stanton, JA
Citation: Ja. Stanton, Aesculapius: A modern tale, J AM MED A, 281(5), 1999, pp. 476-477
Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: Potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor
Authors: Sternfeld, F Guiblin, AR Jelley, RA Matassa, VG Reeve, AJ Hunt, PA Beer, MS Heald, A Stanton, JA Sohal, B Watt, AP Street, LJ
Citation: F. Sternfeld et al., Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: Potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor, J MED CHEM, 42(4), 1999, pp. 677-690
3-(piperazinylpropyl)indoles: Selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents
Authors: Chambers, MS Street, LJ Goodacre, S Hobbs, SC Hunt, P Jelley, RA Matassa, VG Reeve, AJ Sternfeld, F Beer, MS Stanton, JA Rathbone, D Watt, AP MacLeod, AM
Citation: Ms. Chambers et al., 3-(piperazinylpropyl)indoles: Selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents, J MED CHEM, 42(4), 1999, pp. 691-705
3-[3-(Piperidin-1-yl)propyl] indoles as highly selective h5-HT1D receptor agonists
Authors: Russell, MGN Matassa, VG Pengilley, RR van Niel, MB Sohal, B Watt, AP Hitzel, L Beer, MS Stanton, JA Broughton, HB Castro, JL
Citation: Mgn. Russell et al., 3-[3-(Piperidin-1-yl)propyl] indoles as highly selective h5-HT1D receptor agonists, J MED CHEM, 42(24), 1999, pp. 4981-5001
Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles
Authors: van Niel, MB Collins, I Beer, MS Broughton, HB Cheng, SKF Goodacre, SC Heald, A Locker, KL MacLeod, AM Morrison, D Moyes, CR O'Connor, D Pike, A Rowley, M Russell, MGN Moyes, CR O'Connor, D Pike, A Rowley, M Russell, MGN Sohal, B Stanton, JA Thomas, S Verrier, H Watt, AP Castro, JL
Citation: Mb. Van Niel et al., Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles, J MED CHEM, 42(12), 1999, pp. 2087-2104
Risultati: 1-8 |